Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Switching to Iloperidone From Other Antipsychotics in Schizophrenia

ClinicalTrials.gov ID: NCT01207414

Public ClinicalTrials.gov record NCT01207414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Randomized, Multi-center, Open-Label, Iloperidone, (12-24 mg/Day), Flexible Dose Study Assessing Efficacy, Safety and Tolerability of Two Switch Approaches in Schizophrenia Patients Currently Receiving Risperidone, Olanzapine or Aripiprazole

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the clinical outcome of two switching strategies to iloperidone treatment in adult subjects with schizophrenia who require a change in their current antipsychotic treatment of risperidone, olanzapine, or aripiprazole due to suboptimal efficacy and/or safety/tolerability reasons.

Study identification

NCT ID
NCT01207414
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis
Industry
Enrollment
501 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Dec 31, 2011
Completion
Dec 31, 2011
Last update posted
Mar 14, 2013

2010 – 2012

United States locations

U.S. sites
59
U.S. states
20
U.S. cities
49
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226
Comprehensive Neuroscience Cerritos California 90703
ATP Clinical Research Center, Inc. Costa Mesa California 92626
Collaborative Neuroscience Network Garden Grove California 92845
Apostle Clinical Trials, Inc. Long Beach California 90813
Pacific Health Systems National City California 91950
Pacific Research Partners Oakland California 94612
Excell Research, Inc. Oceanside California 92056
University of California, Irvine Orange California 92868
CNRI San Diego San Diego California 92102
Affiliated Research Institute San Diego California 92108
Artemis Institute for Clinical Research San Diego California 92108
Neuropsychiatric Research Center of Orange County Santa Ana California 92701
Viking Clinical Research Temecula California 92591
Collaborative Neuroscience Torrance California 90502
The Hospital of Central Connecticut New Britain Connecticut 06052
Comprenhensive Neuroscience Washington D.C. District of Columbia 20016
Amit K. Vijapura MD & Associates Jacksonville Florida 32256
Scientific Clinical Research North Miami Florida 33161
Atlanta Center for Medical Research Atlanta Georgia 30308
Comprehensive Neuroscience Atlanta Georgia 30328
Northwest Behavioral Research Center Marietta Georgia 30060
Carman Research Smyrna Georgia 30080
Institute for Behavioral Medicine Smyrna Georgia 30080
Alexian Brothers Center for Mental Health Arlington Heights Illinois 60005
Rush University Medical Center, Treatment Research Center Chicago Illinois 60612
University of Illinois at Chicago Chicago Illinois 60612
AMR - Baber Research, Inc. Naperville Illinois 60563
Midwest Center for Neurobehavioral Medicine Oakbrook Terrace Illinois 60181
Louisiana Clinical Research Shreveport Louisiana 71115
Neurobehavioral Medicine Group, Clinical Trials Division Bloomfield Hills Michigan 48302
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307
Precise Research Centers Flowood Mississippi 39232
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63301
Center for Emotional Fitness Cherry Hill New Jersey 08002
CRI World Wide Clinical Research Company Willingboro New Jersey 08046
Albuquerque Neuroscience Albuquerque New Mexico 87109
Neurobehavioral Research Cedarhurst New York 11516
Comprehensive Neuroscience Fresh Meadows New York 11366
Division of Psychiatry Research - Zucker Hills Hospital Glen Oaks New York 11004
Finger Lakes Clinical Research Rochester New York 14618
Behavioral Medical Research Staten Island New York 10305
Richmond Behavioral Associates Staten Island New York 10312
North Coast Clinical Trials Beachwood Ohio 44122
Neurobehavioral Clinical Research Canton Ohio 44718
IPS Research Company Oklahoma City Oklahoma 73103
SP Research, PLLC Oklahoma City Oklahoma 73112
Belmont Center for Comprehensive Treatment Philadelphia Pennsylvania 19131
CRI Worldwide, LLC - Kirkbride Division Philadelphia Pennsylvania 19139
Carolina Clinical Trials Charleston South Carolina 29407
Community Clinical Research, Inc. Austin Texas 78754
KRK Medical Research Dallas Texas 75230
FutureSearch Trials Dallas Texas 75231
InSite Clinical Research DeSoto Texas 75115
Bayou City Research Limited Houston Texas 77007
Claghorn-Lesem Research Clinic, Inc Houston Texas 77008
Mary Ann Knesevich, MD, PA Irving Texas 75062
InSite Clinical Research Plano Texas 75074
Frontier Institute Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01207414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2013 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01207414 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →